Table: Hisamitsu -2019/20 group results

Hisamitsu Pharmaceutical Co

10/04/2020 07:00

Apr 10 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 29, 2020    Feb 28, 2019   Feb 28, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            140.99          143.41                                
                 (-1.7 pct)      (-3.4 pct)                              
  Operating         22.73           22.28                                
                 (+2.0 pct)      (-17.3 pct)                             
  Recurring         25.63           24.65                                
                 (+4.0 pct)      (-12.7 pct)                             
  Net
  Net               18.69           19.20                                
                 (-2.7 pct)      (+0.4 pct)                              
  EPS            227.58 yen      230.08 yen                              
  EPS Diluted    227.30 yen      229.86 yen                              
  Ann Div         83.00 yen       82.50 yen                              
  -Q2 Div         41.50 yen       41.25 yen                              
  -Q4 Div         41.50 yen       41.25 yen                              
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T